Literature DB >> 27723562

Homology modeling of a Class A GPCR in the inactive conformation: A quantitative analysis of the correlation between model/template sequence identity and model accuracy.

Stefano Costanzi1, Matthew Skorski2, Alessandro Deplano2, Brett Habermehl2, Mary Mendoza2, Keyun Wang2, Michelle Biederman2, Jessica Dawson2, Jia Gao2.   

Abstract

With the present work we quantitatively studied the modellability of the inactive state of Class A G protein-coupled receptors (GPCRs). Specifically, we constructed models of one of the Class A GPCRs for which structures solved in the inactive state are available, namely the β2 AR, using as templates each of the other class members for which structures solved in the inactive state are also available. Our results showed a detectable linear correlation between model accuracy and model/template sequence identity. This suggests that the likely accuracy of the homology models that can be built for a given receptor can be generally forecasted on the basis of the available templates. We also probed whether sequence alignments that allow for the presence of gaps within the transmembrane domains to account for structural irregularities afford better models than the classical alignment procedures that do not allow for the presence of gaps within such domains. As our results indicated, although the overall differences are very subtle, the inclusion of internal gaps within the transmembrane domains has a noticeable a beneficial effect on the local structural accuracy of the domain in question. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptors; GPCRs; Homology modeling; Sequence alignment; β(2) adrenergic receptor

Mesh:

Substances:

Year:  2016        PMID: 27723562      PMCID: PMC5138091          DOI: 10.1016/j.jmgm.2016.10.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  47 in total

1.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 3.  The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling.

Authors:  Stefano Costanzi; Keyun Wang
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Construction of phylogenetic trees.

Authors:  W M Fitch; E Margoliash
Journal:  Science       Date:  1967-01-20       Impact factor: 47.728

Review 5.  Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors.

Authors:  Stefano Costanzi; Jeffrey Siegel; Irina G Tikhonova; Kenneth A Jacobson
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.

Authors:  Jie Yin; Juan Carlos Mobarec; Peter Kolb; Daniel M Rosenbaum
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

7.  Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1.

Authors:  Jill E Chrencik; Christopher B Roth; Masahiko Terakado; Haruto Kurata; Rie Omi; Yasuyuki Kihara; Dora Warshaviak; Shinji Nakade; Guillermo Asmar-Rovira; Mauro Mileni; Hirotaka Mizuno; Mark T Griffith; Caroline Rodgers; Gye Won Han; Jeffrey Velasquez; Jerold Chun; Raymond C Stevens; Michael A Hanson
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

8.  Homology modeling of class a G protein-coupled receptors.

Authors:  Stefano Costanzi
Journal:  Methods Mol Biol       Date:  2012

9.  The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines.

Authors:  K Noda; Y Saad; R M Graham; S S Karnik
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Derivation of rules for comparative protein modeling from a database of protein structure alignments.

Authors:  A Sali; J P Overington
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

View more
  5 in total

1.  Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist.

Authors:  Gianni Sagratini; Michela Buccioni; Gabriella Marucci; Elena Poggesi; Matthew Skorski; Stefano Costanzi; Dario Giardinà
Journal:  Bioorg Med Chem       Date:  2018-05-17       Impact factor: 3.641

2.  Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β2 Adrenergic Receptor as a Case Study.

Authors:  Stefano Costanzi; Austin Cohen; Abigail Danfora; Marjan Dolatmoradi
Journal:  J Chem Inf Model       Date:  2019-07-01       Impact factor: 4.956

3.  Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor.

Authors:  Noureldin Saleh; Gunnar Kleinau; Nicolas Heyder; Timothy Clark; Peter W Hildebrand; Patrick Scheerer
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

4.  Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis.

Authors:  Chiara Parravicini; Davide Lecca; Davide Marangon; Giusy Tindara Coppolino; Simona Daniele; Elisabetta Bonfanti; Marta Fumagalli; Luca Raveglia; Claudia Martini; Elisabetta Gianazza; Maria Letizia Trincavelli; Maria P Abbracchio; Ivano Eberini
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

5.  Homology Modeling of Class A G-Protein-Coupled Receptors in the Age of the Structure Boom.

Authors:  Asma Tiss; Rym Ben Boubaker; Daniel Henrion; Hajer Guissouma; Marie Chabbert
Journal:  Methods Mol Biol       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.